Pharmacokinetics of intravenous adriamycin for anhepatic chemotherapy during liver transplantation

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Kitagawa, Tetsushi ^a   Ku, Yonson ^a   Kusunoki, Nobuya ^a   Tominaga, Masahiro ^a   Maeda, Ichiro ^a   Fukumoto, Takumi ^a   Iwasaki, Takeshi ^a   Kuroda, Yoshikazu ^a   Saitoh, Yoichi ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Adriamycin pharmacokinetics; Anhepatic chemotherapy; Liver transplantation; Malignant liver tumor

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; FEMALE; HEART; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG; MALE; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; SKELETAL MUSCLE; URINARY EXCRETION;

EID: 0029853729     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01582.x     Document Type: Article

References (14)

1. Okuda K, Otsuki T, Obata H (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56: 918-928
2. The Liver Cancer Study Group of Japan (1987) Primary liver cancer in Japan. Sixth report. Cancer 60: 1400-1411
3. Belghiti J, Panis Y, Farges O, Benhamou JF, Fekete F (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214: 114-117
4. Sasaki Y, Imaoka S, Fujita M (1987) Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg 206: 40-47
5. Iwatsuki S, Starzl TE, Seahan DG (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214: 221-229
6. Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busutill RW (1990) Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125: 1261-1268
7. Stone MJ, Klintmalm GB, Polter, Husberg BOS, Mennel RG, Ramsay MAE, Flemens EE, Goldstein RM (1993) Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: results in 20 patients. Gastroenterology 104: 196-202
8. Carr BI, Starzl TE, Iwatsuki S, Van Thiel D (1991) Aggressive treatment for advanced hepatocellular carcinoma (HCC): high recurrence rates and prolonged survival. Hepatology 14: 103 A
9. Cherqui D, Piedbois P, Pierga J, Duvoux C, Vavasseur D (1994) Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. Cancer 73: 2721-2726
10. Kam I, Lynch S, Todo S, Dewolf A, McSteen F, Jakab F, Ericzon BG (1986) Low flow venovenous bypass in small dogs and pediatric patients undergoing replacement of the liver. Surg Gynecol Obstet 163: 33-36
11. Robert J (1980) Extraction of anthracycline from biologic fluids for HPLC evaluation. J Liquid Chromatogr 3: 1561-1572
12. Legha SS, Benjamin RS, Mackay B (1982) Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96: 133-139
13. Benjamin RS, Wiernik PH, Bachur NR (1974) Adriamycin chemotherapy-efficacy, safety and pharmacologic basis of an intermittent single high-dose schedule. Cancer 33: 19-26
14. Loveless H, Arena E, Felsted RL (1978) Comparative mammalian metabolism of adriamycin and daunorubicin. Cancer Res 38: 593-598